DUOTRAV

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DUOTRAV contains a combination of these active pharmaceutical ingredients (APIs):

1 Travoprost UNII WJ68R08KX9 - TRAVOPROST

Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways. Read about Travoprost

2 Timolol UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma. Read about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5555J, 9057Q
Country: CA	Health Products and Food Branch	Identifier(s): 02278251
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00890494, 00890502, 16700900, 16930907, 17483190
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 367470813
Country: EE	Ravimiamet	Identifier(s): 1243763, 1243774, 1243785
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06338001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 124870, 573177
Country: FR	Base de données publique des médicaments	Identifier(s): 63633802
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 103205, 103206, 175383, 182540, 201631, 375915, 376320
Country: HK	Department of Health Drug Office	Identifier(s): 55178
Country: IE	Health Products Regulatory Authority	Identifier(s): 22511, 22539, 22560, 22571
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6407
Country: IT	Agenzia del Farmaco	Identifier(s): 037104015
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319820Q1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005140, 1027899, 1027900, 1079985, 1079986, 1079987
Country: NG	Registered Drug Product Database	Identifier(s): A4-3210
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 80888
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11741
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100160611
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64597001
Country: SG	Health Sciences Authority	Identifier(s): 13722P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1903061, 20833041
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504612042
Country: ZA	Health Products Regulatory Authority	Identifier(s): A40/15.4/0511